Get started
Author

Julian Pinsolle

Lung cancer trends and tumor characteristic changes over 20 years (2000–2020): Results of three French consecutive nationwide prospective cohorts’ studies
2022 · Didier Debieuvre, Olivier Molinier, et al. · The Lancet Regional Health - Europe · 90
PDF
ALK fusion variants detection by targeted RNA-next generation sequencing and clinical responses to crizotinib in ALK-positive non-small cell lung cancer
2017 · Anne McLeer-Florin, Michael Duruisseaux, et al. · Lung Cancer · 55
Trends in response rate and survival in small-cell lung cancer patients between 1997 and 2017
2019 · Mickaël Lattuca-Truc, Jean-François Timsit, et al. · Lung Cancer · 40
PDF
First-line single-agent pembrolizumab for PD-L1-positive (tumor proportion score ≥ 50%) advanced non-small cell lung cancer in the real world: impact in brain metastasis: a national French multicentric cohort (ESCKEYP GFPC study)
2022 · Renaud Descourt, Laurent Greillier, et al. · Cancer Immunology Immunotherapy · 33
Pharmacokinetic herb‐drug interaction between ginger and crizotinib
2019 · Bruno Revol, Elodie Gautier‐Veyret, et al. · British Journal of Clinical Pharmacology · 33
Paclitaxel–bevacizumab combination in advanced non-squamous non-small-cell lung cancer (NSCLC): AVATAX, a retrospective multicentric study
2022 · Geoffroy Bilger, Anne-Claire Toffart, et al. · Therapeutic Advances in Medical Oncology · 15
PDF
Translating Systems Medicine Into Clinical Practice: Examples From Pulmonary Medicine With Genetic Disorders, Infections, Inflammations, Cancer Genesis, and Treatment Implication of Molecular Alterations in Non-small-cell Lung Cancers and Personalized Medicine
2019 · Julian Pinsolle, Anne McLeer-Florin, et al. · Frontiers in Medicine · 11
PDF
Partial response of pulmonary adenocarcinoma with symptomatic brain metastasis to nivolumab plus high-dose oral corticosteroid: a case report
2017 · Hélène Pluchart, Julian Pinsolle, et al. · Journal of Medical Case Reports · 11
PDF
Impact of systematic advanced care planning in lung cancer patients: A prospective study
2019 · N. Denis, J.-F. Timsit, et al. · Respiratory Medicine and Research · 9
PDF
Different pathways to lung cancer diagnosis in a real-life setting
2024 · Juliette Raëth, Cécile Malbert, et al. · Respiratory Medicine and Research · 8
Three-Year Overall Survival of Patients With Advanced Non–Small-Cell Lung Cancers With ≥50% PD-L1 Expression Treated With First-Line Pembrolizumab Monotherapy in a Real-World Setting (ESCKEYP GFPC Study)
2023 · Chantal Decroisette, Laurent Greillier, et al. · Journal of Immunotherapy · 7
Risk factors for early mortality from lung cancer: evolution over the last 20 years in the French nationwide KBP cohorts
2024 · T.C.T. Hoang, D. Debieuvre, et al. · ESMO Open · 6
PDF
Immune checkpoint inhibitors and hospitalization at home in France
2021 · Elisa Gobbini, Anne-Claire Toffart, et al. · Bulletin du Cancer · 6
PDF
A Rare Fusion of CLIP1 and ALK in a Case of Non–Small-Cell Lung Cancer With Neuroendocrine Features
2019 · Julian Pinsolle, Julie Mondet, et al. · Clinical Lung Cancer · 5
PDF
Venous thrombotic events and impact on outcomes in patients treated with first-line single-agent pembrolizumab in PD-L1 ≥ 50% advanced non small cell lung cancer
2023 · Hélène Doubre, Laurent Greillier, et al. · Journal of Cancer Research and Clinical Oncology · 4
PDF
Utilisation concomitante du nivolumab et d’immunosuppresseurs chez un patient greffé rénal
2019 · H. Pluchart, L. Ferrer, et al. · Revue des Maladies Respiratoires · 4
PDF
Efficacy of weekly paclitaxel-bevacizumab combination in advanced non squamous non-small cell lung cancer (NSCLC): A retrospective multicentric study
2019 · G. Bilger, P. Boré, et al. · Annals of Oncology · 4
PDF
Les avancées dans la prise en charge des cancers bronchopulmonaires : ce qui change pour le réanimateur
2019 · J. Pinsolle, N. Terzi, et al. · Médecine Intensive Réanimation · 4
PDF
COVID-19 among lung cancer patients: Data from a real-life prospective French multicentric study
2024 · O. Molinier, J. Pinsolle, et al. · Respiratory Medicine and Research · 3
Efficacy of weekly paclitaxel-bevacizumab combination in advanced non squamous non-small cell lung cancer (NSCLC) progressing after immune checkpoint inhibitors - AVATAX , a retrospective multicentric study: Preliminary data
2019 · S.C. Valery, C. Chouaid, et al. · Annals of Oncology · 3
First-line pembrolizumab monotherapy for PD-L1-positive (TPS ≥ 50%) advanced non-small cell lung cancer (aNSCLC) in the real world: A national French bispective multicentric cohort—ESCKEYP trial (GFPC 05-2018).
2021 · Renaud Descourt, Laurent Greillier, et al. · Journal of Clinical Oncology · 2
Trends in response rate and survival in small cell lung cancer patients between 1997 and 2017.
2018 · Mickaël Lattuca-Truc, Matteo Giaj Levra, et al. · Journal of Clinical Oncology · 2
PDF
Unusually prolonged pemetrexed cytotoxicity in a patient with a lung adenocarcinoma: a case report
2017 · Linda Sakhri, Julian Pinsolle, et al. · Journal of Medical Case Reports · 2
Real-life management and outcomes of octogenarians with non-small-cell lung cancer: A 10-year evolution
2026 · Romain Corre, Isabelle Monnet, et al. · European Journal of Cancer · 1
Compassionate Access to Brigatinib for Patients with Non-small-cell Lung Cancer Harboring a ROS1 Rearrangement: Results from the BRIGAROS Study
2025 · Jean Mourlanette, Gaelle Rousseau-Bussac, et al. · Targeted Oncology · 1
Works count: 61
Citation count: 361
H-index: 9
I10-index: 8
Year
Topic
Type